IgE-neutralizing UB-221 mAb, distinct from omalizumab and ligelizumab, exhibits CD23-mediated IgE downregulation and relieves urticaria symptoms

Author:

Kuo Be-Sheng,Li Chao-Hung,Chen Jiun-Bo,Shiung Yu-Yu,Chu Chia-YuORCID,Lee Chih-HungORCID,Liu Yaw-Jen,Kuo Je-Hung,Hsu Cindy,Su Hsiao-Wen,Li Ywan-Feng,Lai Annie,Ho Yueh-Feng,Cheng Yi-NingORCID,Huang Hong-XuanORCID,Lung Meng-Chung,Wu Ming-Syue,Yang Fu-Hong,Lin Chen-Han,Tseng William,Yang Jasper,Lin Chia-Yin,Tsai Pei-Hua,Chang Heng-Kwei,Wang Yi-Jen,Chen Techeng,Lynn Shugene,Liao Mei-June,Wang Chang Yi

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference68 articles.

1. Allergic diseases and asthma: a global public health concern and a call to action;Pawankar;World Allergy Organ J,2014

2. Burden and socioeconomics of asthma, allergic rhinitis, atopic dermatitis and food allergy

3. The atopic march: progression from atopic dermatitis to allergic rhinitis and asthma;Bantz;J Clin Cell Immunol,2014

4. The atopic march

5. The atopic march and atopic multimorbidity: Many trajectories, many pathways

Cited by 29 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Therapeutic monoclonal antibodies in allergy: Targeting IgE, cytokine, and alarmin pathways;Immunological Reviews;2024-08-19

2. Mast cell stabilizers: from pathogenic roles to targeting therapies;Frontiers in Immunology;2024-08-01

3. Emerging Therapeutics in Chronic Urticaria;Immunology and Allergy Clinics of North America;2024-08

4. Urticaria Beyond Omalizumab: What is Next?;Current Treatment Options in Allergy;2024-07-30

5. Single-Domain Antibodies—Novel Tools to Study and Treat Allergies;International Journal of Molecular Sciences;2024-07-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3